BiographyProfessor Hankey's main research interests include epidemiological studies and clinical trials of treatment strategies for acute stroke and stroke prevention such as the Perth Community Stroke Study [PCSS], Australian Co-operative Research on Subarachnoid Haemorrhage [ACROSS] study, and Health in Men Study [HIMS], for which he is a co-principal investigator; the international, multicentre CHARISMA, AMADEUS, BOREALIS and ROCKET-AF trials, for which he was an executive steering committee member; the international VITAmins To Prevent Stroke [VITATOPS] trial, for which he was the principal investigator; and the AFFINITY trial of fluoxetine for stroke recovery, for which he is co-principal investigator.
Professor Hankey has contributed 604 articles to peer-reviewed medical journals (Editorials 52, Review articles 85, Original Articles 365, Case reports 32, Letters to the Editor 32, and published commentaries 38). His work has been cited 31,646 times; his H-index is 76 (76 publications with > 76 citations) and i10-index is 279 (279 publications with > 10 citations). He is also the author or co-author of 10 books (the most recent Hankey’s Clinical Neurology, 2nd edition, 2014), 20 book chapters and 12 Guidelines on aspects of stroke and clinical neurology. He has delivered 508 invited lectures at international (n=295), national (n=123), and local (n=90) scientific meetings.